Please login to the form below

Not currently logged in
Email:
Password:

Porterhouse Medical Group joins imc group

Agency will be a key addition to imc's growing network of international offices

Global healthcare communications and insights research agency Porterhouse Medical Group is joining imc group with the support of Waterland Private Equity.

Porterhouse offers strategic medical communications as well as publication planning and insights research. The agency will be a key addition to imc’s growing network of international offices and team, which already serve some of the largest drug companies in the world.

Imc is a healthcare communications and consulting agency headquartered in London, with expertise across a broad range of therapy areas. Combining the Porterhouse and imc teams will strengthen their capabilities on both sides of the Atlantic.

“We’re excited to be building the future of strategic healthcare communications as we join forces with imc group, together extending our reach and service provision across North America and Europe,” said Jon Hallows, co-founder and joint MD at Porterhouse Medical Group.

“We’re confident that Porterhouse and imc together will continue to deliver innovative solutions for our clients during their most challenging period yet,” he added.

“We’re delighted to be welcoming Porterhouse to the imc family. Combined, we will have over 165 employees across four countries, offering seamless solutions for all our clients,” said Shairose Ebrahim, imc group co-founder, president and chief executive officer.

“Together we can build on the fantastic capabilities that imc and Porterhouse collectively have, I couldn’t be more thrilled,” she added.

7th August 2020

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...